E95 | How pharma R&D can use AI to accelerate exploration, understanding, and insights

11 snips

Jan 9, 2024

Dr. Andree Bates is joined by Casper Wilstrup, founder and CEO of Abzu, to discuss how Abzu's QLattice Explainable AI algorithm can accelerate disease understanding and insights in pharma R&D. They explore applications in biomarkers, RNA therapeutics, and reducing drug development timelines. They also discuss the impact of the EU AI Act on pharma's AI use and Abzu's vision for the future of their technology.

Ask episode

AI Snips

Chapters

Transcript

Episode notes

ANECDOTE

Casper's Background

Casper Wilstrup has been engaged with computers since 1981, starting his first company in 1999. His journey through entrepreneurship and venture capital shaped his focus on symbolic AI at Abzu.

INSIGHT

Symbolic AI's Revival

Symbolic AI, which offers explanations for phenomena, has been overshadowed by neural networks and deep learning. Reviving this approach can lead to better understanding in various scientific fields.

INSIGHT

QLattice Functionality

The QLattice algorithm generates hypotheses without needing large datasets, enabling researchers to understand complex phenomena. It can produce explanations even with minimal or no data.

Get the Snipd Podcast app to discover more snips from this episode

Get the app

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Casper Wilstrup, founder and CEO of Abzu.

They discuss how Abzu's QLattice Explainable AI algorithm can be used to accelerate disease understanding, drug design, and insights in pharma R&D. Casper explains how the QLattice generates hypotheses to explain phenomena using symbolic AI without requiring large datasets.

They explore applications in areas like biomarkers, RNA therapeutics, and reducing drug development timelines. The episode provides insights into how regulations like the EU AI Act may impact pharma's AI use and Abzu's vision for the future of their technology.

In this episode you will learn:

How Abzu's QLattice algorithm uses symbolic AI to generate hypotheses without large datasets
Applications of explanatory AI in areas like biomarkers, RNA therapeutics, and disease understanding
Considerations for pharma companies regarding regulations like the EU AI Act
Abzu's work with partners in pharma R&D to accelerate drug development timelines
The company's vision for expanding access to their explanatory AI technology

Click to connect with Dr. Andree Bates for more information in this episode: https://eularis.com/

To find out more about Abzu and to get in touch with Casper and his team, head to https://www.abzu.ai/

AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business.

This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget.

As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses.

This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more.

Resources:

Dr. Andree Bates LinkedIn | Facebook | Twitter